Global Colloidal Bismuth Pectin Capsules Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Colloidal Bismuth Pectin Capsules Market Research Report 2024
Colloidal bismuth pectin capsules are capsules made of colloidal bismuth pectin, which is a complex of pectin and bismuth with an indeterminate composition. This product is mainly used to treat gastric ulcer and gastritis.
According to Mr Accuracy reports new survey, global Colloidal Bismuth Pectin Capsules market is projected to reach US$ 66 million in 2029, increasing from US$ 51 million in 2022, with the CAGR of 3.7% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Colloidal Bismuth Pectin Capsules market research.
Key manufacturers engaged in the Colloidal Bismuth Pectin Capsules industry include China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical, Shanxi Ante Bio-pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, North China Pharmaceutical Company, Harbin Pharmaceutical Group, Shanxi PUDE Pharmaceutical, Lionco Pharmaceutical Group, Guilin Hwasun Pharmaceutical and Renhe Pharmacy, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Colloidal Bismuth Pectin Capsules were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Colloidal Bismuth Pectin Capsules market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Colloidal Bismuth Pectin Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical
Shanxi Ante Bio-pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Shanxi PUDE Pharmaceutical
Lionco Pharmaceutical Group
Guilin Hwasun Pharmaceutical
Renhe Pharmacy
Guangdong Pidi Pharmaceutical
Lionco Pharmaceutical Group
Gaoyou Zhaokang Pharmaceutical
Sichuan Emeishan Jinding Pharmaceutical
Charoen Pokphand Group
Guizhou Warmen Pharmaceutical
Sichuan Kelun Pharmaceutical
ZHEJIANG DND PHARMACEUTICAL
Luoyang Junshan Pharmaceutical
Anhui Yongshengtang Pharmaceutical Limited Liability Company
SHANGHAI XIANDAI HASEN (SHANGQIU) PHARMACEUTICAL
Segment by Type
50mg/Pcs
100mg/Pcs
Other
Stomach Ulcer Treatment
Gastritis Treatment
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Colloidal Bismuth Pectin Capsules report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Colloidal Bismuth Pectin Capsules market is projected to reach US$ 66 million in 2029, increasing from US$ 51 million in 2022, with the CAGR of 3.7% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Colloidal Bismuth Pectin Capsules market research.
Key manufacturers engaged in the Colloidal Bismuth Pectin Capsules industry include China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical, Shanxi Ante Bio-pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, North China Pharmaceutical Company, Harbin Pharmaceutical Group, Shanxi PUDE Pharmaceutical, Lionco Pharmaceutical Group, Guilin Hwasun Pharmaceutical and Renhe Pharmacy, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Colloidal Bismuth Pectin Capsules were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Colloidal Bismuth Pectin Capsules market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Colloidal Bismuth Pectin Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical
Shanxi Ante Bio-pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Shanxi PUDE Pharmaceutical
Lionco Pharmaceutical Group
Guilin Hwasun Pharmaceutical
Renhe Pharmacy
Guangdong Pidi Pharmaceutical
Lionco Pharmaceutical Group
Gaoyou Zhaokang Pharmaceutical
Sichuan Emeishan Jinding Pharmaceutical
Charoen Pokphand Group
Guizhou Warmen Pharmaceutical
Sichuan Kelun Pharmaceutical
ZHEJIANG DND PHARMACEUTICAL
Luoyang Junshan Pharmaceutical
Anhui Yongshengtang Pharmaceutical Limited Liability Company
SHANGHAI XIANDAI HASEN (SHANGQIU) PHARMACEUTICAL
Segment by Type
50mg/Pcs
100mg/Pcs
Other
Segment by Application
Stomach Ulcer Treatment
Gastritis Treatment
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Colloidal Bismuth Pectin Capsules report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source